Related Experiment Videos
Increased expression of interleukin 6 mRNA in cardiac myxomas
Abstract:
In three patients with cardiac myxoma increased expression of interleukin 6 (IL-6) mRNA was found in the myxoma tissue by polymerase chain reaction (PCR) and in situ hybridisation. These cases suggest that IL-6 is overproduced in the myxoma tissue and secreted into the systemic circulatory system. This might contribute to the systemic inflammatory or autoimmune manifestations seen in cardiac myxoma. This study also showed the usefulness of PCR and in situ hybridisation for the evaluation of mRNA expression in small samples of tissue.
Insights
Cardiac myxoma tissue shows increased interleukin-6 (IL-6) mRNA expression, suggesting IL-6 overproduction contributes to systemic inflammation. Polymerase chain reaction (PCR) and in situ hybridization are useful for analyzing small tissue samples.
Area of Science:
- Molecular Biology
- Immunology
- Cardiology
Background:
- Cardiac myxomas are primary heart tumors often associated with systemic symptoms.
- The role of specific cytokines, like interleukin-6 (IL-6), in the pathogenesis of cardiac myxoma remains to be fully elucidated.
Observation:
- Increased expression of interleukin-6 (IL-6) mRNA was detected in cardiac myxoma tissue from three patients.
- Analysis was performed using polymerase chain reaction (PCR) and in situ hybridization techniques.
Findings:
- Cardiac myxoma tissue overproduces and likely secretes IL-6 into the systemic circulation.
- The elevated IL-6 levels may be responsible for the inflammatory and autoimmune manifestations observed in patients with cardiac myxoma.
Implications:
- IL-6 may play a significant role in the systemic effects of cardiac myxoma.
- PCR and in situ hybridization are valuable tools for assessing mRNA expression in limited tissue samples, aiding in the understanding of cardiac myxoma pathophysiology.